Antigen recognition by T cells bearing  T cell receptors (TCRs) is restricted by major histocompatibility complex (MHC). However, how antigens are recognized by T cells bearing  TCRs remains unclear. Although  T cells can recognize nonclassical MHC, it is generally thought that recognition of antigens is not MHC restricted. Here, we took advantage of an in vitro system to generate antigen-specific human T cells and show that melanoma-associated antigens, MART-1 and gp100, can be recognized by  T cells in an MHC-restricted fashion. Cloning and transferring of MART-1-specific  TCRs restored the specific recognition of the initial antigen MHC/peptide reactivity and conferred antigen-specific functional responses. A crystal structure of a MART-1-specific  TCR, together with MHC/peptide, revealed distinctive but similar docking properties to those previously reported for  TCRs, recognizing MART-1 on HLA-A*0201. Our work shows that antigen-specific and MHC-restricted  T cells can be generated in vitro and that MART-1-specific  T cells can also be found and cloned from the naïve repertoire. These findings reveal that classical MHC-restricted human  TCRs exist in the periphery and have the potential to be used in developing of new TCR-based immunotherapeutic approaches.
INTRODUCTION
Successful adaptive immune responses rely on the appropriate recognition of antigens by T lymphocytes (1) . In the case of  T cells, their T cell receptors (TCRs) recognize processed antigen peptides presented by the major histocompatibility complex (MHC) (2) . In contrast,  TCRs can recognize unprocessed and nonpeptide antigens that are not presented by MHC (1, 3, 4) , and it has been proposed that antigen recognition by some  TCRs resembles that of immunoglobulin (1, 5) .
Most  T cells present in human blood express a V9/V2 TCR (1), which can recognize tumor cells and microbial infections via nonpeptide phosphoantigens (pAgs) generated by the mevalonate pathway (1, 4) . However, pAg-mediated stimulation of V9/V2 T cells was shown to be through binding of pAg to the internal domain of the butyrophilin-3A1 protein, rather than directly to the TCR (6) . On the other hand, V1-expressing  T cells are rare in the blood, representing less than 10% of all  T cells (7) , but are found at higher frequency mostly in mucosal sites and can engage nonclassical MHC molecules on the surface of virally infected or tumor cells (1, 4, (8) (9) (10) .  T cells, expressing either V9/V2 or V1 TCRs, have been found within tumor-infiltrating lymphocytes (TILs) in melanomas (1, 7, (11) (12) (13) . The significance of  T cells within TILs and the role of each subset in the evolution of the disease are largely unknown.
Here, we investigated whether human  T cells could recognize melanoma-associated antigens (MAAs) and achieve this specificity by engaging MHC-presented peptide antigens. To this end, we used an in vitro system to generate antigen-specific human T cells, which revealed that MAAs MART-1 and gp100 can be recognized by  T cells in an MHC-restricted fashion. Cloning and transferring of MART-1-specific  TCRs to T cells restored the specific recognition of the initial antigen MHC/peptide (MHCp) reactivity and conferred antigen-specific functional responses. A three-dimensional crystal structure of the complex between a MART-1-specific  TCR and HLA-A2 (human leukocyte antigen-A2)/MART-1 revealed distinctive but similar properties to those previously reported for  TCRs. Our work shows that MHC-restricted antigen-specific  T cells can be generated in vitro and that, similarly, MART-1-specific  T cells can also be found and cloned from the naïve repertoire of peripheral T cells. These findings reveal that classical MHC-restricted human  TCRs are present in the periphery and have the potential to be used in developing of new TCR-based immunotherapeutic approaches.
RESULTS

Human  T cells generated in vitro recognize MHCp antigens
To investigate whether  T cells can recognize tumor-associated antigens, we took advantage of an in vitro system to generate human T cells from hematopoietic stem/progenitor cells (HSPCs) (14) (15) (16) , so that both  and  lineages of T cells could be interrogated. We reasoned that T cells generated in vitro from HSPCs, using the OP9-DL system (14, 17) , would include cells reactive to self-antigens, such as MAAs (18) . As previously reported (15) , HSPCs cultured on OP9-DL4 cells can differentiate into functional CD8 + T cells expressing a broad TCR repertoire (16) ; therefore, MAA-specific T cells would be expected to be found in these cultures. S1 , bottom rows). We directly examined for the presence of T cells that can recognize MAAs; in particular, we looked for MART-1 (Melan-A) or gp100 reactivity. Analysis of day 55 cocultures revealed the presence of HLA-A2/MART-1 (heteroclitic peptide)-specific cells, within the DP and CD8 + SP subsets (Fig. 1A , left panels, first column). These cells were observed after an enrichment for CD8 + cells (Fig. 1A , right panels, second column). These findings show that MAA-specific CD8 + SP T cells can be generated from HSPCs in vitro.
We further characterized the in vitro-generated CD8 + T cells and observed that both  and  TCR-bearing cells were present (Fig. 1B, top row) , with CD8 being exclusively expressed on  TCR + cells. Analysis of CD8 + T cells showed that a few of these cells were reactive to the MAAs MART-1 and gp100 (Fig. 1B) . We also noticed the presence of  TCR + cells that showed reactivity for these MAAs (Fig. 1B and fig. S2 ). These findings revealed that the repertoire of both  and  T cells generated in vitro had reactivity to HLA/peptide-dependent antigens.
Peripheral human  T cells recognize MHCp antigens
The generation of HLA-A2/MART-1-specific  T cells from HSPCs in vitro was unexpected and raised the key question as to whether  T cells with similar HLA/peptide reactivity are present in the periphery. To this end, we isolated naïve T cells from HLA-A2 + umbilical cord blood and, after enrichment for CD4 −  TCR-expressing cells, stimulated them with MART-1 peptide-pulsed antigen-presenting cells (Fig. 1C) . After 18 days, analysis of the cultures for the presence of  T cells showed that a majority were V1 + , whereas V9 + made up a small fraction that did not appear to show any reactivity to HLA-A2/ MART-1. However, among the  T cells, a clear but small subset of HLA-A2/MART-1-reactive cells was present. Similarly,  T cells also contained a small subset of HLA-A2/MART-1-specific cells. These findings show that  (V1) T cells present in the normal naïve repertoire show specificity for HLA/peptide antigen recognition.
Cloning of human  T cells that recognize MHCp antigens
Classical MHC-restricted  T cell clones have been extensively characterized both structurally and functionally. Although, recognition of classical MHCp by  T cells has been reported (19) , it is not understood how this interaction is mediated. Thus, the ability to grow and maintain  T cell clones with HLA-A2/MART-1 specificity was necessary to characterize how these cells recognize antigen and to validate whether this reactivity was TCR dependent (20) . To this end, we generated MART-1-specific  T cell clones from both CD8 + SP and DP subsets, as indicated in Fig. 1A (red circles). After single cell sorting, MART-1-specific T cell clones were derived from CD8 + SP at a higher plating efficiency than from DP cells (table S1). A total of 33 MART-1-specific  T cell clones were generated from three independent experiments; all of these showed positive staining with HLA-A2/ MART-1 dextramers, but not with either gp100 or HIV peptide dextramers ( Fig. 2A and fig. S3 ). All 33 clones expressed V1, and none expressed V2 and/or V9 (Fig. 2B , showing four representative clones, and fig. S3 , showing seven additional clones from three independent experiments). In summary, we were successful in identifying MART-1-specific  T cell clones from HPSC-derived T cells generated in vitro that belonged to the V1 subset of  T cells. In addition, we were also able to expand MART-1-specific  T cells from adult peripheral blood mononuclear cells (PBMCs) ( fig. S4) fig. S8A ). Effector function proteins were expressed (granzyme B) and detected (CD107a) on MART-1-specific  T cells after stimulation ( fig. S8B ).
Human  TCRs transfer recognition of MHCp antigens
To conclusively show that HLA-A2/MART-1 reactivity by the  T cells was TCR dependent, we cloned and sequenced the TCR- and TCR- chains of three independent CD8 + T cell clones generated in vitro; all TCR- chains contained V1 segments, whereas two of the TCR- chains were V8, and one was V4 (table S3) . Of note, the complementarity determining region 3 (CDR3) regions showed that all three TCRs were unique. Retroviral expression constructs encoding individual TCR- and TCR- chains from two  T cell clones (3C2 and 5F3) were transduced into Jurkat 76 (J76) or Jurkat 76 CD8 + (J76CD8) T cells (2) . As shown in Fig. 2C , HLA-A2/MART-1 reactivity was seen by both 3C2 and 5F3  TCR-transduced J76, as well as J76CD8 T cells, showing that the  TCRs were sufficient to confer the original MART-1 recognition to the J76 T cells.
As expected, untransduced J76 T cells only showed background reactivity to HLA-A2/MART-1 dextramers, whereas a control  T cell clone (49) showed the anticipated specific MART-1 reactivity (Fig. 2C) . Although transferring the  TCRs to J76 or J76CD8 T cells restored HLA-A2/MART-1 reactivity, we further evaluated their specificity by testing for reactivity against a panel of different HLA/ peptide dextramers. The  TCR (3C2)-reconstituted J76 (Fig. 2D) or J76CD8 ( fig. S9 ) T cells were specific for HLA-A2/MART-1 but did not recognize either gp100 or influenza matrix protein (MP) peptides presented on HLA-A2. In addition, MART-1 [wild-type (WT) peptide] presented on HLA-B*3501 was not recognized by the  TCRtransduced J76 T cells. We also showed that the addition of HLA-A2/ MART-1 dextramers to two T cell clones (3C2  TCR and 1C2  TCR) lowered the staining levels for TCR expression ( fig. S10 ). These data suggest that recognition of MART-1 by  TCRs was specific for the HLA-A2/MART-1 complex and may be similarly constrained as the recognition by  TCRs, and compatible with the notion that recognition of MART-1 by  TCRs appears to be MHC restricted.
Human  TCRs transfer functional recognition MHCp antigens
Although the analysis using HLA dextramers strongly suggested that MAA-specific  TCRs recognize MART-1 in the context of HLA-A2, we further tested whether this recognition was sufficient to functionally activate T cells bearing these TCRs.  TCR-transduced J76 T cells specifically produced IL-2 in response to MART-1-pulsed T2 cells (HLA-A*0201 + ), whereas no response was apparent with other peptides tested ( fig. S11 ). Similarly,  TCR-transduced J76 T cell showed the same specificity for MART-1, albeit higher levels of IL-2 were produced by these cells. Furthermore, we compared  TCR (3C2)-transduced activated cord blood PBMCs (fig. S12) to established control  TCR T cell lines (specific for MART-1 or gp100) and showed that 3C2-transduced T cells were able to lyse only MART-1 peptide-pulsed T2 cells, whereas gp100-pulsed T2 cells showed background killing (Fig. 2E) . Thus, MART-1-specific  TCRs ectopically expressed by T cells (J76 or PBMCs) can transfer functional responsiveness in an HLA/peptide-dependent manner.
Molecular interaction of human  TCRs with MHCp antigens
To understand the molecular basis of the interaction of the 5F3 and 3C2 TCRs with HLA-A2/MART-1, we expressed recombinant forms of the extracellular domains of the TCRs and HLA-A2 either in insect cells or by refolding Escherichia coli-expressed inclusion bodies.
Using biolayer interferometry (BLI), we demonstrated a direct interaction between the 5F3 and 3C2 TCRs with HLA-A2/MART-1, but no detectable interaction between HLA-A2 complexed with the control gp100 peptide ( fig. S13 ). The 5F3 and 3C2 TCRs bind the refolded HLA-A2/ 2 M/MART-1 construct with distinctly different K d values of 2.9 and 71 M, respectively, exhibiting an about 20-fold difference in affinity. To probe the contribution of the TCR chains to the HLA-A2 interaction, we analyzed a TCR (named 1A6) generated from the  chain Representative analysis of one of the four transduced  TCR chains is shown (n ≥ 3). (E) Cytotoxic T cell assay of sorted activated cord blood PBMCs transduced with 3C2  TCR, as described in fig. S12 , showing specific percent lysis at the indicated effector to target ratios of MART-1-or gp100-pulsed T2 cell targets. Representative analysis of  TCR-transduced PBMCs is shown (n = 3). MART-1-speficic  T cell line, gp100-specific  T cell line, and nontransduced PBMCs are also shown.
of 5F3 and the  chain of 3C2 and measured the affinity of this hybrid construct to refolded HLA-A2 using BLI. 1A6 bound HLA-A2/ MART-1 with an affinity (9 M) similar to that of 5F3, suggesting that the  chain shared between 1A6 and 5F3 contributes most of the binding energy of the interaction with HLA-A2/MART-1. Had the  chain predominated energetically, we would anticipate that the affinity of the 1A6 TCR would more closely resemble the 3C2 TCR. These affinities are within the range of those previously measured for V1  TCRs/ligand interactions with nonclassical MHC molecules CD1c and CD1d (21-23) and comparable to  TCR affinity to HLA-A2/  2 M/MART-1 (24, 25) . Furthermore, the apparent bias toward use of the V1 domain for binding and docking, as revealed by the chain swapping experiment, is reminiscent of the V1 domain bias in recognition of CD1d, wherein the  chain contributes only minimally or not at all (22, 23) . Unexpectedly, affinity measurements of the TCRs with the insect cell-expressed, trimeric single-chain constructs of HLA-A2/ 2 M/ MART-1 showed that whereas the 5F3 and 1A6 TCRs recognize this construct similarly to that of the refolded HLA-A2/ 2 M/MART-1, the 3C2 TCR does not ( fig. S13C ). This trimeric construct has the MART-1 peptide covalently linked to  2 M that is then linked to the HLA-A2 heavy chain with glycine-serine linkers (26) ; these linkers are absent in the refolded HLA-A2 construct. We hypothesize that the failure of the 3C2 TCR to bind to the trimeric construct is due to obstruction by the glycine-serine linker connecting the MART-1 peptide and  2 M, which would extend up and out of the HLA-A2 groove. This finding suggests that the docking orientation of the 3C2 TCR differs from that of the 5F3 TCR, which binds to both refolded and trimeric HLA-A2 constructs equally. A similar pattern was found in the binding results of the hybrid 1A6 TCR, which binds the trimeric version and refolded HLA-A2/MART-1 with similar affinities, suggesting that not only does the shared  chain of 5F3 TCR contributes most of the binding energy but also it dictates the docking footprint. All three  TCRs did not bind CD1c, a known ligand for a subset of V1  T cells (21, 27) , reflecting their specificity for HLA-A2. In addition, these TCRs show explicit binding specificity for the MART-1 peptide, because they did not interact with the irrelevant gp100 peptide ( fig. S13, D and F) , reflecting our results from functional assays presented earlier. Overall, our binding experiments provide conclusive biochemical evidence that these  TCRs recognize HLA-A2/ MART-1 directly and specifically.
Crystal structure of a human  TCR with MHCp antigen Generally, the structural information related to ligand recognition by  TCR is very limited in comparison to  TCR. Only three complex structures with nonclassical MHC-like molecules (T22 and CD1d) are available (22, 23, 28) . To understand the molecular basis of  TCR recognition of classical MHC, here, HLA-A*0201, we crystallized the 5F3 TCR in complex with single-chain trimeric HLA-A2/ 2 M/ MART-1 and solved the structure to 2.75 Å (table S4). The TCR and HLA-A2/MART-1 proteins were well resolved in the electron density maps and revealed the TCR docked onto HLA-A2 in a diagonal binding orientation, where the two TCR chains straddle the MART-1 peptide, reminiscent of the classical docking mode of  TCRs on MHCp (29) , similar to that of the HLA-A2/MART-1-specific MEL5 TCR, but distinctly different from a V1  TCR recognition of CD1d/ sulfatide complex (Fig. 3A) (22) . The docking angle difference between 5F3 and MEL5 is ~22°, well within the range of docking angles noted for  TCRs that recognize HLA-A2/MART-1 (Fig. 3B) . Curiously, in the 5F3/HLA-A2/MART-1 complex structure, the CDR1 and CDR2 loops of the  chain are positioned over the 1 helix of HLA-A2, and the CDR1 and CDR2 loops of the  chain are positioned over the 2 helix, with both CDR3 loops centrally positioned over the peptide. Although direct homology between the , , , and  gene segments is unclear, the  and  gene segments are embedded in the same chromosomal locus (30) , sometimes share V segments (31) , and therefore are generally considered to be homologous. With this interpretation, the docking orientation of the 5F3 would then be considered to be in a flipped (more than 180°) orientation to that of a classical CD8 +  TCR, which docks generally with the  chain over the 1 helix and the  chain over the 2 helix. However, interpreting the structure from a different perspective, both  and  chains use D segments during rearrangement, which generates a highly diverse (and typically longer) CDR3 loop in these chains. The orientation that we observe in the 5F3 TCR positions the highly diverse CDR3 in a similar position to that of the CDR3 loop, suggesting that the 5F3 orientation may be following docking principles inherent in  TCR recognition of MHC.
All six CDR loops of the 5F3 TCR are used in engaging the HLA-A2/ MART-1 composite surface ( Fig. 3B and table S5 ). In the contacts with HLA-A2, the CDR loops of  chain exclusively interact with the 1 helix, and contacts of the  chain are biased toward the 2 helix. The total buried surface area (BSA) of the TCR/HLA-A2/MART-1 interface is ~2127 Å 2 , a value that is in the higher range of  TCR/MHC complexes, with the BSA distributed between the individual  and  chains (59 and 41% BSA, respectively). From the MHCp, nearly onefifth of the BSA (19%) was contributed by the peptide, whereas HLA-A2 accounted for 81%. In the complexes of the HLA-A2/MART-1-reactive TCRs, MEL5, DMF4, and DMF5 (24, 25) , there is more BSA with the peptide, ranging from 29 to 34% (table S6) , suggesting the 5F3 TCR may be slightly less peptide centric than these  TCRs.
Of the six CDR loops of the 5F3 TCR, only the CDR3 and CDR1 loops make contacts with the peptide. The junctionally encoded CDR3 residues W98 and D99 are involved in multiple contacts (Fig. 3C and fig. S14 ), with the aromatic side chain of W98 providing an anchoring role through insertion between the centrally twisted region of MART-1 peptide and the 1 helix of HLA-A2. The W98 side chain forms van der Waals contacts with the A3, G4, and I7 residues of MART-1, and D99 is positioned centrally over the peptide and forms one hydrogen bond with G4 and van der Waals contacts with I5 and G4 residues (Fig. 3C, inset) . Tyrosine-32 is the only residue from the  chain that contributes to peptide recognition through a van der Waals interaction with I5 (Fig. 3C, fig. S14 , and table S5). Similarly, in the MEL5  TCR/HLA-A2 complex, an analogous CDR1 residue, Q31, interacts extensively with the MART-1 peptide.
Mutational footprinting analysis of human  TCRs with MHCp antigens
Both the 5F3 and 3C2 TCRs use the V1 and V8 domains in their TCRs, only differing in the sequences of their CDR3 loops. To compare the docking strategies of these two TCRs, we determined their energetic footprints by using alanine-scanning mutagenesis of the residues in the HLA-A2  helices. Seventeen amino acid residues that are fully exposed on the 1 and 2 helices of HLA-A2 were individually mutated to alanine, and these mutants were refolded with the MART-1 peptide and used in BLI measurements with the  TCRs. WT HLA-A2 was also used as a control, and the effect of the mutation was calculated as a ratio of mutant K d to WT K d . This analysis indicated that the 5F3 and 3C2 TCRs interact differently with HLA-A2 (Fig. 4) . Residues R65, K68, R75, and V76 are critical for 5F3 TCR as alanine mutation of these residues resulted in more than fourfold reductions of affinities, consistent with the contacts observed in the crystal structure. Q72A and E154A mutants have more than a twofold effect on affinities, owing to their multiple interactions with the 5F3 TCR (Fig. 4A, left panel) . The mutational analysis resulted in a different profile of interactions for the 3C2 TCR, where mutants R75A, Y84A, and H151A resulted in more than twofold reduction, V76A resulted in more than threefold reduction, and K146A and T163A resulted in more than fourfold reduction (Fig. 4A, right panel) .
Mapping of a color-coded representation of these mutational results onto a surface representation of HLA-A2 provides a view of the docking footprints of the 3C2 TCR in relation to that of 5F3 (Fig. 4B) . The energetic hotspot of 5F3 TCR is mostly focused on the 1 helix, reflecting the dominant role played by the V1 domain of 5F3 TCR in MHC recognition (Fig. 4B, left panel) . The energetic hotspot of 3C2 TCR differs from that of the 5F3 TCR and is instead distributed across the 1 and 2 helices near the C terminus of the peptide (Fig. 4B, right panel) . This finding is consistent with the inability of the 3C2 TCR to engage with the trimeric HLA-A2/ 2 M/MART-1 construct, because the linker between the C terminus of the peptide and  2 M as hypothesized would disrupt the 3C2 TCR interaction (Fig. 4C) . Our TCR footprinting analysis indicates that these  TCRs, despite using identical V gene segments in their TCRs, use different docking strategies to recognize the same HLA-A2/peptide antigen complex.
DISCUSSION
Human T cells can be generated from HSPCs in vitro, and these cultures are able to give rise to both  and  T cell lineages. Here, we show that antigen-specific human  T cells can be generated in vitro, which can recognize MAAs MART-1 and gp100 in an MHC-restricted fashion. Cloned  TCRs were able to transfer MART-1 specificity to T cells, allowing for the specific recognition of the initial antigen MHCp reactivity and conferring antigen-specific functional responses. Structural analysis of crystals from a MART-1-specific  TCR, together with MHCp, revealed distinctive binding properties to those previously reported for  TCRs. This work establishes that MHCrestricted antigen-specific  T cells can be generated in vitro and that, similarly, MART-1-specific  T cells can also be found and cloned from the naïve repertoire of peripheral T cells.
Our molecular analyses demonstrate a direct interaction between  TCRs and HLA-A2/MART-1 with affinity ranges within that documented for agonist  TCR/MHCp interactions. The crystal structure of the MART-1-specific  TCR 5F3 provides a molecular snapshot of how  T cells can recognize classical MHCp. The docking orientation is notably similar to  TCR recognition of the same MHCp complex, with a convergent focus of the diverse, D segment containing CDR3 and  loops on the same location of the MART-1 peptide. Our footprinting analyses of the 5F3 and 3C2 TCRs show that multiple docking strategies are used in  TCR binding despite bearing the same V and V domains, suggesting that the sequences of the CDR3 loops factor strongly into how the TCRs engage the MHCp composite surface. Whether the 3C2 TCR adopts a variation on the diagonal docking orientation awaits further structural analysis.
Although our work revealed the presence of MHC-restricted HLA-A2/MART-1-specific  T cells in both naïve cord blood and adult PBMCs, it is still unclear as to when these cells normally arise, and to which tissues, if any, these T cells traffic and/or reside remains to be elucidated. In addition, whether  T cells that recognize MHCpdependent antigens have a role in immune surveillance of melanomas (or other cancers), and importantly whether they have immunomodulatory functions, also remains to be examined.
In the thymus and in the periphery,  T cells recognize antigens in the context of self-MHC-a property named MHC restriction by . Although this phenomenon has been deemed unique to  T cells, the exact nature of antigen recognition by  T cells is still largely unknown. It is unclear how many defined  T populations exist in humans and how these cells recognize and respond to their ligands through their TCR (1, 4) . Documented cases of  T cell recognition reveal that  TCRs can recognize antigen directly, but other examples demonstrate the requirement for MHC molecules (nonclassical or MHC-like), either alone or with presented antigen, such as the case with the lipid-presenting MHC-like proteins CD1c and CD1d. Cases for recognition of classical MHCp are few, usually limited to a single T cell clone, and none have been characterized at the molecular level. Here, we show that  T cells with MHCrestricted reactivity to MAAs can not only be generated from HSPC in vitro but are also present among cord blood and adult PBMCs. Elucidating whether MHC restriction applies more broadly to  T cells has critical implications for our general understanding of the surveillance function of these cells and for designing potential cell-based immunotherapies. To this end, the in vitro generation of  T cells with MAA specificity offers an alternative approach for the application of tumortargeted T cells.
MATERIALS AND METHODS
Umbilical cord blood samples and OP9-DL4 culture system OP9-DL4 cells were generated and maintained as previously described (17) . Human umbilical cord blood samples were obtained by syringe extraction and collected in a blood-pack unit containing citrate phosphate dextrose anticoagulant (Baxter Healthcare, Deerfield, IL) from consenting mothers after delivery in accordance to approved guidelines established by the Research Ethics Board of Sunnybrook Health Sciences Centre. Within 24 hours of collection, cord blood mononuclear cells were isolated as previously described (35) . Sorted CD34 + CD38
− cord blood stem cells were plated on OP9-DL4 cells and cultured as previously described (35) . (36) , artificial antigen-presenting cells (aAPC), phytoagglutinin (PHA; 5 g/ml), and IL-2 (100 IU/ml). Wells were examined for cell growth on days 18 to 21 after plating, and cells were expanded using stimulators described above every 3 to 4 weeks.
Generation of MART-1-reactive clones
Heteroclitic MART-1 TCR  clones and cell lines as well as gp100-specific CD8 + T cell lines were generated from ex vivo cord blood samples following the same approach. , and PHA in the presence of IL-7 (5 ng/ml) and IL-2 (100 IU/ml). Wells were refed after 2 weeks, and clones were analyzed by flow cytometry for the presence of V1 + and MART-1 + cells after 3 weeks. Positive clones were then used for functional assays.
Generation of  TCR cells from cord blood naïve or adult PBMCs
Crystallization, x-ray crystallographic data collection, molecular replacement, and refinement Single-chain HLA-A*02/ 2 M/MART-1 and the 5F3 TCR were expressed in insect cells as described above. The purified HLA-A*02/  2 M/MART-1 protein was treated with endoglycosidase-F3 at 37°C for 2.5 hours to remove N-linked glycosylation. Histidine-tagged HLA-A*02/ 2 M/MART-1 was purified by Ni-nitrilotriacetic acid (NTA) agarose column, and endoglycosidase-F3 was removed by washing with Hepes buffer saline (HBS). In next step, the 8× histidine tag was removed by treating with carboxypeptidase (SigmaAldrich) for overnight at room temperature (22°C). EDTA (1 mM) was added to protein sample to quench the protease activity, and last, the protein was purified with Superdex 200 size-exclusion chromatography. 5F3 TCR was expressed in Hi5 cells as described earlier.
After Ni-NTA purification, TCR was treated with 3C protease overnight at 4°C to remove zipper and histidine tag. TCR was passed through the Ni-NTA column to remove any undigested TCR. TCR was treated with endoglycosidase-F3 to remove glycosylation for 2.5 hours at 37°C. Last, TCR was purified using Mono S cation exchange and Superdex 200 size-exclusion chromatography (GE Healthcare). HLA-A*02 and 5F3 fractions were checked in SDS-polyacrylamide gel electrophoresis for purity. HLA-A*02/ 2 M/MART-1 and 5F3 TCR were mixed together at an equi molar concentration. Proteins were concentrated to 5.5 mg/ml at 4°C and screened for crystals using sitting drop vapor diffusion method combining 0.5 l of protein with 0.5 l of reservoir solution in a 96-well plate (Douglas Scientific). Diamond-shaped crystals were obtained in 0.1 M tris (pH 8.5) and 23% (v/v) poly(ethylene glycol) methyl ether 550. Crystals were run on a gel to confirm for HLA-A*02/ 2 M/MART-1 and 5F3 complex. Crystals were cryocooled in mother liquor solution supplemented with 20% glycerol before cryocooling at 100 K liquid nitrogen. X-ray datasets were collected on Pilitus detector at beamline 24ID-C, Advanced Photon Sources, Argonne National Laboratory. Data were indexed, integrated, and scaled with HKL2000. HLA-A*02 [Protein Data Bank (PDB) code: 2AV7] without any lig and and 9C2 TCR (PDB code: 4LHU) without the CDR sequences were used as search models for molecular replacement in Phaser in CCP4i (37, 38) . The solution generated one HLA-A*02 molecule adjacent to one 5F3 TCR molecule, and symmetry analysis showed that 5F3 TCR is on top of HLA-A*02 molecule and recognizing the peptide through the CDR loops. Initially, rigid body and restrained refinements were carried out in Phenix (39) . The iterative model building was performed in Coot (40) , peptide and N-acetylglucosamine (NAG) were introduced in the model, and refinement including translation/liberation/screw was carried out for the final model. All the refinements were performed by taking random 5% reflections and excluding them for Rfree. Contacts were analyzed with Contact/N-contact program in CCP4. Buried surface was analyzed with AREAIMOL in CCP4i and PDBePISA (www. ebi.ac.uk/pdbe/pisa/). All the figures were generated with PyMOL (Schrödinger Scientific).
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